The University of Copenhagen is excited to announce NADMED as Tier 4 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.
NADMED Sponsors the 12th Aging Research & Drug Discovery Conference - ARDD 2025
Copenhagen, Denmark –NADMED, a world leader in NAD measuring technology, is proud to announce its sponsorship of the 12th Aging Research and Drug Discovery (ARDD) Meeting, the world’s largest industry event dedicated to aging research and longevity. The conference, taking place in Copenhagen later this month, brings together leading scientists, clinicians, and industry innovators shaping the future of healthy aging.
NADMED develops cutting-edge technology for the precise measurement of redox metabolites critical to human health and longevity. Its advanced assay kits provide laboratories with the ability to accurately measure four forms of NAD (NAD+, NADH, NADP+, NADPH) and two forms of glutathione (GSSG, GSH). Precise measurement of NAD can provide insights into how the body maintains energy production, repairs DNA, and combats stress, key factors in combating age-related conditions and enhancing overall well-being. Moreover, NAD levels are closely linked to numerous diseases, including heart disease, cancer, neurodegeneration, metabolic disorders, and mitochondrial dysfunction.
NADMED will showcase its advanced tests at ARDD 2025, including its next-generation assay kits that eliminate the limitations of previous measurement methods. Traditional approaches to NAD measurement have often been costly, time-consuming, and prone to inaccuracies. NADMED’s technology solves these challenges with a fast, reliable, and cost-effective solution that integrates seamlessly into standard laboratory workflows.
Already adopted by dozens of institutions worldwide, the kits are setting a new standard for NAD research and clinical diagnostics.
During ARDD 2025, NADMED will highlight how precise NAD measurement can transform research and clinical practice, offering insights into:
-
The role of NAD in metabolism, cellular repair, and longevity.
-
The link between NAD levels and age-related diseases such as cardiovascular disease, neurodegeneration, cancer, and metabolic disorders.
-
How reliable NAD data can drive the development of targeted therapies and interventions to support healthy aging.
Jari Närhi, CEO and Co-Founder of NADMED, commented, “Understanding and accurately measuring NAD is a game-changer for aging research and medicine. At ARDD 2025, we are excited to demonstrate how our technology empowers scientists and clinicians with the tools they need to unlock the biology of aging and develop effective interventions.”
For more information, visit www.nadmed.com
ARDD has grown to become the largest and most important conference in longevity biotechnology. Each year, ARDD brings together a unique mix of academic luminaries, biotech innovators, investors, top pharmaceutical executives, physicians, and related health care professionals to discuss the latest advancements in aging research and the event provides unique opportunities to connect with brilliant minds, fostering collaboration and showcasing groundbreaking research in the field.
“We are extremely honored to host Professors Meldal and Levitt at ARDD2025. Their Nobel prize winning discoveries have been instrumental for drug development and molecular design in part through modelling of proteins and molecules, and in part through the ability to easily create new molecules. It is therefore a great pleasure that they are joining our conference.” said Morten Scheibye-Knudsen, MD, Ph.D., University of Copenhagen.
“We are really excited for ARDD2025, especially with Nobel Laureates Morten Meldal and Michael Levitt joining us. Their groundbreaking contributions have had a lasting impact on drug discovery, and having them at the conference is sure to make it an unforgettable experience.” said Daniela Bakula, Ph.D., University of Copenhagen.
“For 12 years, the Aging Research and Drug Discovery (ARDD) forum grew in size and in quality. It became the world’s main platform for academia-pharma-startup-investor partnership and dialogue. In 2025, the conference will feature the Nobel laureates, pharmaceutical industry executives and healthcare delivery leaders. ARDD is a unique platform for advancing longevity biotechnology around the world.” said Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine.
“At ARDD we strive to highlight the cutting-edge research and clinical applications in a new discipline of healthy longevity medicine. Having Nobel laureates join and speak at the ARDD conference underscores the critical importance of grounding longevity science and medicine in evidence-based, scientifically rigorous approaches.” said Prof.Dr.Evelyne Bischof, the organizer of the Longevity Medicine Days.
Aging research has become a great platform for advancing drug discovery with blockbuster potential, with pharmaceutical leaders like Novartis, Biogen, and Eli Lilly actively supporting this transformative field. ARDD has established itself as the go-to venue where scientists and pharma companies collaborate, share insights, and launch aging-focused research initiatives. In 2024, industry leaders such as Eli Lilly, Novartis, Regeneron, Biogen, and Lundbeck presented their latest research at ARDD, highlighting the meeting's pivotal role in advancing healthspan and longevity science. Be part of ARDD 2025 and contribute to shaping the future of medicine.
For further information, images or interviews, please contact:
ardd@pharma.ai
About Aging Research for Drug Discovery Conference
At ARDD, leaders in the aging, longevity, and drug discovery field will describe the latest progress in the molecular, cellular and organismal basis of aging and the search for interventions. Furthermore, the meeting will include opinion leaders in AI to discuss the latest advances of this technology in the biopharmaceutical sector and how this can be applied to interventions. Notably, this year we will have a special day called Longevity Medicine Day, specifically for physicians where the leading-edge knowledge of clinical interventions for healthy longevity will be described. ARRD intends to bridge clinical, academic and commercial research and foster collaborations that will result in practical solutions to one of humanity's most challenging problems: aging. Our quest to extend the healthy lifespan of everyone on the planet.